Extended release pharmaceutical tablet of metformin

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20030170302A1
SERIAL NO

10309193

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides an extended release pharmaceutical tablet containing: (i) a core comprising by weight, based on the core weight, about 70% to about 99% metformin and pharmaceutically acceptable excipients; and (ii) a coating permeable to metformin. The extended release tablet of the invention exhibit a dissolution profile such that after about 2 hours, from about 7% to about 60% of the metformin is released; after about 4 hours, from about 15% to about 90% of the metformin is released; after about 8 hours, from about 50% to about 100% of the metformin is released; after about 12 hours, more than about 75% of the metformin is released.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOVAIL LABORATORIES INCCHELSTON PK BLDG 1 GROUND FLOOR COLLYMORE ROCK ST MICHAEL WEST INDIES

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Schmidtt, Benoit Irvine, CA 1 20
Seth, Pawan Irvine, CA 52 1033

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation